Insider sale
COMPASS THERAPEUTICS, INC.
$5.68M
3.57M shares
What this filing means
ORBIMED CAPITAL LLC plans to sell 3.57M shares of COMPASS THERAPEUTICS, INC. valued at approximately $5.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/9/2025ACC: 0000947871-25-000375
3.57M
Shares to sell
$5.68M
Approx. market value
3.57M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Public Offering
Cash
11/4/2021
3.57MTotal acquired3.57M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/4/2021 | Public Offering Cash | 3.57M | — |
| Total | 3.57M | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
3.57M
Market value
$5.68M
4/9/2025
Total
Units
3.57M
Value
$5.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/9/2025 | 3.57M | $5.68M | Nasdaq Stock Market | Planned |
| Total | 3.57M | $5.68M | ||